← The Wire
MIRMNasdaq
Mirum Pharmaceuticals, Inc.
Pharmaceutical Preparations · DE · CIK 1759425
Mirum Pharmaceuticals transforms rare disease treatment with approved medicines and pipeline candidates
$6.06B
Market cap
$123.00
Last close
-0.6%
1D
+14.1%
5D
964K
Volume
Price · last 39 sessions+16.3%
May 4L $91.83 · H $123.77Jun 29
146
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 18, 20268-KMaterial Agreement · New Debt / ObligationMay 18, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 20268-KCompany UpdateMay 4, 20268-KCompany UpdateApr 27, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-K/ACompany UpdateApr 8, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 25, 2026SC 13D/ASC 13D/AJan 27, 20268-KAcquisition / Disposition · Reg FD DisclosureJan 26, 20268-KResults of Operations · Reg FD DisclosureJan 12, 20268-KCompany UpdateDec 19, 20258-KMaterial Agreement · Equity IssuanceDec 19, 20258-KMaterial Agreement · Equity IssuanceDec 8, 20258-KCompany UpdateNov 17, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteMay 30, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 14, 2025DEF 14ADEF 14AApr 14, 202510-K10-KFeb 26, 20258-KResults of OperationsFeb 26, 20258-KResults of Operations · Reg FD DisclosureJan 13, 202510-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KCompany UpdateJun 17, 20248-KShareholder VoteJun 6, 20248-KCompany UpdateMay 31, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KMar 15, 20248-KResults of OperationsFeb 28, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GJan 31, 20248-KExecutive ChangeJan 16, 20248-KResults of Operations · Reg FD DisclosureJan 8, 20248-KCompany UpdateDec 18, 2023424B5424B5Nov 2, 202310-Q10-QNov 2, 20238-KResults of OperationsNov 2, 20238-K/ACompany UpdateNov 2, 20238-KCompany UpdateOct 17, 20238-KCompany UpdateOct 13, 2023SC 13GSCHEDULE 13GSep 18, 20238-KExecutive ChangeSep 11, 20238-KAcquisition / Disposition · Equity IssuanceSep 5, 20238-KExecutive ChangeAug 30, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 3, 20238-KMaterial Agreement · Equity IssuanceJul 17, 20238-KShareholder VoteJun 13, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AMay 1, 2023DEF 14ADEF14AMay 1, 20238-KMaterial Agreement · Agreement TerminatedApr 17, 20238-KResults of Operations · Company UpdateApr 12, 20238-KExecutive ChangeApr 6, 20238-KCompany UpdateMar 10, 202310-K10-KMar 8, 20238-KResults of OperationsMar 8, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GFeb 3, 20238-KExecutive Change · Results of OperationsJan 9, 20238-KExecutive ChangeDec 19, 20228-KCompany UpdateDec 13, 20228-KCompany UpdateNov 29, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 2022
Insider Activity
In the 90 days to Mar 16, 2026: 1 insider bought $9.0M · 7 sold $16.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 40,985 | $91.98 | $3.8M |
| Mar 16, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 16,515 | $91.98 | $1.5M |
| Mar 16, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 7,287 | $91.98 | $670K |
| Mar 16, 2026 | Quan JoanneCHIEF MEDICAL OFFICER | Sell | 7,287 | $91.98 | $670K |
| Mar 16, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 4,732 | $91.98 | $435K |
| Mar 16, 2026 | Ramasastry SairaDirector | Sell | 2,000 | $90.76 | $182K |
| Feb 13, 2026 | Ramasastry SairaDirector | Sell | 2,000 | $102.09 | $204K |
| Feb 2, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 9,108 | $103.30 | $941K |
| Feb 2, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 2,631 | $103.30 | $272K |
| Feb 2, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 968 | $103.30 | $100K |
| Jan 26, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 6,831 | $96.19 | $657K |
| Jan 26, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 3,143 | $96.19 | $302K |
| Jan 26, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 1,053 | $96.19 | $101K |
| Jan 26, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 842 | $96.19 | $81K |
| Jan 23, 2026 | Heron Patrick JDirector | Buy | 131,425 | $68.48 | $9.0M |
| Jan 22, 2026 | Peetz ChristopherCHIEF EXECUTIVE OFFICER | Sell | 7,098 | $93.33 | $662K |
| Jan 22, 2026 | Radovich PeterPRESIDENT AND COO | Sell | 2,382 | $93.33 | $222K |
| Jan 22, 2026 | Quan JoanneCHIEF MEDICAL OFFICER | Sell | 1,822 | $93.33 | $170K |
| Jan 22, 2026 | Bjerkholt EricCHIEF FINANCIAL OFFICER | Sell | 1,421 | $93.33 | $133K |
| Jan 22, 2026 | Howe JolandaSVP, GLOBAL CONTROLLER | Sell | 926 | $93.33 | $86K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance